Hinge Health (HNGE) Cash & Equivalents (2024 - 2026)

Hinge Health (HNGE) has 3 years of Cash & Equivalents data on file, last reported at $186.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 35.29% year-over-year to $186.7 million; the trailing twelve-month figure through Mar 2026 stood at $186.7 million (down 35.29% YoY), and the FY2025 full-year result was $208.0 million, down 30.85% from the prior year.
• Cash & Equivalents slipped to $186.7 million in Q1 2026, from $208.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $300.8 million in Q4 2024 to a low of $186.7 million in Q1 2026.
• A 3-year average of $237.5 million and a median of $225.3 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents fell 16.49% in 2025 and slumped 35.29% in 2026, its largest moves.
• Tracing HNGE's Cash & Equivalents over 3 years: stood at $300.8 million in 2024, then sank by 30.85% to $208.0 million in 2025, then slipped by 10.25% to $186.7 million in 2026.
• Business Quant data shows HNGE's Cash & Equivalents at $186.7 million in Q1 2026, $208.0 million in Q4 2025, and $214.0 million in Q3 2025.